Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withdrawal of Beta-Blockers and ACE Inhibitors in Recovered DCM
NCT02770443Terminated
- Sponsor
- McGill University
- Start
- Feb 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of carvedilol in dilated cardiomyopathy (DCM) (2 arms), sponsored by McGill University. Primary endpoint: Number of patients that become symptomatic at 1 year. Started Feb 2016; status: terminated.
02
Drugs
carvedilol
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT02770443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770443.